Journal article
Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects
Birth defects research. A Clinical and molecular teratology, Vol.97(8), pp.515-531
08/2013
DOI: 10.1002/bdra.23137
PMCID: PMC5893146
PMID: 23716465
Abstract
Nitrosatable drugs, such as secondary or tertiary amines and amides react with nitrite in an acidic environment to form N-nitroso compounds, teratogens in animal models. Vitamin C is a known nitrosation inhibitor.
Using data from the National Birth Defects Prevention Study, we assessed nitrosatable drug exposure and vitamin C intake during the first trimester among 11,606 case-mothers of infants with oral clefts, limb deficiencies (LDs), or congenital heart defects and 6807 control-mothers of infants without major birth defects during 1997-2005. Daily intake of vitamin C was estimated from maternal interviews that elicited information about supplement use and dietary intake.
With no reported use of nitrosatable drugs as the referent group, a lower odds ratio (OR) was observed for transverse LDs among births to mothers exposed to secondary amine drugs and daily vitamin C supplementation (adjusted odds ratio [aOR] 1.2, 95% confidence interval [CI] 0.83-1.8) compared with women taking these drugs and no supplementation (aOR 2.7, 95% CI 1.5-4.6). The OR for longitudinal LDs associated with secondary amine exposure was lower with daily dietary vitamin C intake ≥85 mg (aOR 1.2, 95% CI 0.68-2.0) compared with <85 mg (aOR 1.9, 95% CI 1.2-3.1). Daily vitamin C supplementation in combination with higher dietary vitamin C intake reduced associations between nitrosatable drug exposures and limb deficiencies and atrial septal defects not otherwise specified.
Prenatal dietary and vitamin C supplement intake may diminish the association between nitrosatable drug exposure during pregnancy and selected birth defects.
Details
- Title: Subtitle
- Prenatal exposure to nitrosatable drugs, vitamin C, and risk of selected birth defects
- Creators
- Mayura U Shinde - Texas A&M Health Science Center, School of Rural Public Health, College Station, Texas 77843-1266, USA. shinde@srph.tamhsc.eduAnn M VuongJean D BrenderMartha M WerlerKatherine E KelleyJohn C Huber JrJoseph R SharkeyQi ZhengLucina SuarezPeter H LangloisMark A CanfieldPaul A RomittiSadia MalikNational Birth Defects Prevention Study
- Resource Type
- Journal article
- Publication Details
- Birth defects research. A Clinical and molecular teratology, Vol.97(8), pp.515-531
- DOI
- 10.1002/bdra.23137
- PMID
- 23716465
- PMCID
- PMC5893146
- NLM abbreviation
- Birth Defects Res A Clin Mol Teratol
- ISSN
- 1542-0752
- eISSN
- 1542-0760
- Publisher
- Wiley; United States
- Grant note
- U01 DD000492 / NCBDD CDC HHS U01 DD000494 / NCBDD CDC HHS 3R01ES015634-03S1 / NIEHS NIH HHS R01 ES015634 / NIEHS NIH HHS U01DD000494 / NCBDD CDC HHS 5R01ES015634 / NIEHS NIH HHS
- Language
- English
- Date published
- 08/2013
- Academic Unit
- Epidemiology; Biostatistics
- Record Identifier
- 9983995135102771
Metrics
17 Record Views